堃博医疗-B(02216.HK) 公布，自主研发的BroncTru 途扩一次性使用经支气管镜扩张导管近日取得欧盟医疗器械法规(欧盟MDR)CE认证，预期为进一步拓展欧洲及其他认可CE认证的市场奠定基础。目前该产品已取得中国NMPA、美国FDA及欧盟MDR CE注册批准，并已在台湾地区、印尼、泰国及马来西亚上市。(gc/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻
Source Link堃博医疗-B(02216.HK) 公布，自主研发的BroncTru 途扩一次性使用经支气管镜扩张导管近日取得欧盟医疗器械法规(欧盟MDR)CE认证，预期为进一步拓展欧洲及其他认可CE认证的市场奠定基础。目前该产品已取得中国NMPA、美国FDA及欧盟MDR CE注册批准，并已在台湾地区、印尼、泰国及马来西亚上市。(gc/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.